2 recruiting, 1 active not recruiting, 1 not yet recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Recruiting 2, Active not recruiting 1, Not yet recruiting 1 |
Follow dabrafenib: new trials by email Literature Review of dabrafenib trials Research Report on dabrafenib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study Dabrafenib, Trametinib, Selpercatinib - Thyroid Neoplasms | Phase 4 | Not yet recruiting | Fujian Medical University | 335 | 2025-07-01 | 2025-06-08 |
| A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer dabrafenib plus trametinib with or without PD-1 antibody, entrectinib or larotrectinib with or without anti-PD-1 antibdoy, pralsetinib or selpercatinib with or without anti-PD-1 antibdoy - Advanced Thyroid Cancer Patients Who Received Target Therapy | Phase 4 | Recruiting | Fudan University | 800 | 2020-01-01 | 2025-08-14 |
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| Dabrafenib and/or Trametinib Rollover Study dabrafenib, trametinib - Melanoma, Non Small Cell Lung Cancer | Phase 4 | Recruiting | Novartis Pharmaceuticals | 100 | 2018-01-26 | 2026-11-10 |
Glioma (2) · Astrocytoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Ganglioglioma (1) · Ganglioneuroma (1) · Glioblastoma (1) · Histiocytosis, Langerhans-Cell (1) · Lung Neoplasms (1) · Melanoma (1) · Neuroblastoma (1) · Neurocytoma (1) · Neurofibroma, Plexiform (1) · Neurofibromatosis 1 (1) · Oligodendroglioma (1) · Thyroid Neoplasms (1)
Novartis Pharmaceuticals (2) · Fudan University (1) · Fujian Medical University (1)
China (3) · Argentina (2) · Canada (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Japan (2) · Netherlands (2) · Russia (2) · Spain (2) · United States (2) · Australia (1) · Austria (1) · Belgium (1)
Dongmei Ji, M.D (1) · Qinghai Ji, M.D (1) · Yansong Lin, M.D (1) · Yu Wang, M.D (1)
2023 (2)